Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic Collaboration with Weizmann Institute of Science
31 janv. 2024 07h00 HE
|
Orange Grove Bio
CINCINNATI, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Orange Grove Bio, a drug investment and development firm, today announced that it has established a new strategic collaboration with Bina, the...
Orange Grove Bio Subsidiary Awarded $2.05 Million SBIR Phase II Grant to Advance Development of Novel Platelet Preservation Technology
28 sept. 2023 06h00 HE
|
Orange Grove Bio
Orange Grove Bio subsidiary, Preservation Bio, awarded $2.05 Million SBIR phase II grant to advance development of novel platelet preservation technology
Orange Grove Bio Expands Academic Collaboration Activities Internationally Through New Strategic Partnerships
23 mars 2023 06h30 HE
|
Orange Grove Bio
CINCINNATI, March 23, 2023 (GLOBE NEWSWIRE) -- Orange Grove Bio, a drug investment and development firm, today announced that it has established new strategic collaborations with the Yonsei...
Magnuson Center for Entrepreneurship at Dartmouth College and Orange Grove Bio Establish Collaboration to Strengthen Biotech Ecosystem and Support Development and Commercialization of Novel Therapeutics
10 nov. 2022 07h00 HE
|
Orange Grove Bio
CINCINNATI, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Orange Grove Bio, a drug investment and development firm, today announced the establishment of a strategic collaboration with the Magnuson Center for...
Orange Grove Bio Provides Corporate Update Highlighting Key Leadership Appointments and Establishment of New Academic Collaboration
23 juin 2022 06h30 HE
|
Orange Grove Bio
John C. Byrd, M.D., Renowned Cancer Clinician and Researcher, Named Chair of Scientific Advisory Board New Collaboration with Northeast Ohio Medical University Further Demonstrates Company’s...
Cincinnati Children’s Hospital Medical Center and Orange Grove Bio Establish Collaboration to Develop and Commercialize Novel Therapeutics
09 mars 2022 06h30 HE
|
Orange Grove Bio
CINCINNATI, March 09, 2022 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm, and Cincinnati Children’s Hospital Medical Center today announced the...
SV Investment and Orange Grove Bio Establish Partnership to Jointly Source and Develop Novel Therapeutics in the U.S. and Korea
08 févr. 2022 07h00 HE
|
Orange Grove Bio
Collaboration will Focus on Identifying Most Promising Research Emerging from Biotech Companies in Korea and U.S. for Licensing, Investment and Company Creation Partnership Supports Orange Grove’s...
The University of Colorado Anschutz Medical Campus and Orange Grove Bio to Collaborate on Development and Commercialization of Novel Therapies
08 déc. 2021 07h00 HE
|
Orange Grove Bio
CINCINNATI, Ohio and AURORA, Colo., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm, and the University of Colorado Anschutz Medical Campus (CU...
The University of Pittsburgh and Orange Grove Bio Establish Partnership to Develop and Commercialize Novel Therapeutics
17 nov. 2021 07h00 HE
|
Orange Grove Bio
NEW YORK and PITTSBURGH, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm, and the University of Pittsburgh today announced the establishment of...
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments Establish Partnership with Albert Einstein College of Medicine to Support Development of Novel Therapeutics
21 oct. 2021 06h00 HE
|
Orange Grove Bio
Mentorship Program Designed to Support Researchers and Clinical Scientists in Streamlining Translation of Novel Discoveries into New Therapeutic Candidates Pitch Contest to Award Winners Funding to...